• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » COVID-19 testing on Abbott lab machines running far short of need

COVID-19 testing on Abbott lab machines running far short of need

April 9, 2020 By Nancy Crotti

Abbott’s m2000 RealTime system (Image from Abbott)

U.S. laboratories are not running enough COVID-19 diagnostic tests using Abbott (NYSE:ABT) m2000 RealTime machines, according to Dr. Deborah Birx, White House coronavirus response coordinator.

During last night’s White House briefing, Birx said that 80% of the Abbott machines in 120 laboratories across the country are not running, despite the availability of 1 million tests. Abbott said in March, when it received FDA emergency use authorization for a coronavirus test, that each of the more than 175 m2000 systems in U.S. labs can run up to 470 tests in 24 hours. A the time, the company promised to deploy additional m2000 systems as needed.

“I made a big push and Abbott was extraordinary about getting those out to the labs,” Birx said last night. “I mean, this is not sitting in a warehouse. These are physically in these laboratories, sitting there right now.”

U.S. laboratories have only run 88,000 tests in 3 weeks off of those machines with a million test kits — 10% of their capacity, Birx noted. The high-throughput machines could have screened 100% of the healthcare workers across the country who needed testing, she added.

Abbott m2000 systems are located in academic medical centers and hospital laboratories across the country, which typically use them to test for HIV, hepatitis and similar conditions, according to a report by Bloomberg News. The problem may be with getting the machines to the areas with the highest demand for COVID-19 tests, with the appropriate testing supplies and trained staff to run them 24 hours a day, the Bloomberg report said.

“In our interactions with customers, we understand that the majority are running Covid-19 tests,” Abbott spokeswoman Kimberly Modory told Bloomberg. “Some of these labs are working to expand their capacity by increasing staff and supplies to run more shifts. In some instances states and cities are working to establish ways to send the samples to the labs that have capacity.”

Abbott also launched a 5-minute COVID-19 diagnostic test in March for use in physicians’ offices, urgent care clinics and hospital emergency departments.

Birx said she had calls scheduled with the laboratories for 8 p.m. EST yesterday and with hospital CEOs this morning. The White House has made no further statements on the subject today.

Abbott, the American Hospital Association and the American Clincial Laboratory Association did not immediately respond to requests for comment.

Filed Under: Featured, Hospital Care, Lab Instruments & Supplies Tagged With: Abbott, coronavirus, COVID-19

More recent news

  • Presidio wins FDA IDE for ultra-low frequency neuromod, hires new CFO
  • Epiminder study backs implantable EEG tech
  • Neurent Medical wins FDA nod for next-gen chronic rhinitis treatment
  • Medtronic unveils “MiniMed” as name for soon-to-be separated Diabetes unit
  • Medtronic issues safety notice for Hugo surgical robot console in Europe

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy